Julie Neville is a Dermatology physician. OpenAlex indexes 10 publications with 415 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
123 Western Hills Blvd
Cheyenne, WY 820093446
Telephone
307-635-0226Registry record last updated 19 Sept 2007.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20255 payments
- Regeneron Healthcare Solutions, Inc.Program year20252 payments
- Lilly USA, LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
42.9%First-generation cephalosporins24.7%Cephalexin100%Part D≥68 patientsTetracycline-class Drug10.5%Doxycycline Hyclate100%Part D≥21 patients+ 1 more class in this area
Sensory organs
18.2%Corticosteroid18.2%Clobetasol Propionate72%Hydrocortisone28%Part D≥30 patientsRespiratory
15.5%RNA Synthetase Inhibitor Antibacterial15.5%Mupirocin100%Part D≥40 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
PubMed
2007 - Status update: hospital-acquired and community-acquired methicillin-resistant Staphylococcus aureus.
PubMed
2007 - Increase in Procedures Performed at Dermatology Office Visits from 1995 to 2001
Dermatologic Surgery
2006
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”